These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 23791064)

  • 1. [Surveillance of adverse events following immunization in Henan Province, China between 2010-2011].
    Ye Y; Wang CS; Ma YT; Lu MX; Zhang XX; Zhang YY; Guo WS
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):466-71. PubMed ID: 23791064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adverse events following immunization: AEFI in 17 children between 0 and 2 years of age].
    Taraszkiewicz F; Bogus-Parafieniuk W; Ołdak E; Sulik A
    Przegl Epidemiol; 1994; 48(4):505-9. PubMed ID: 7597191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis on the adverse event following immunization (AEFI) after supplementary immunization activity of measles attenuated live vaccine in Sichuan province in 2007-2008].
    Wang J; Liu QL; Yang CM
    Zhongguo Yi Miao He Mian Yi; 2009 Jun; 15(3):219-22. PubMed ID: 20084885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis on the surveillance of adverse events following immunization in China, 2007-2008].
    Wu WD; Liu DW; Wu BB
    Zhongguo Yi Miao He Mian Yi; 2009 Dec; 15(6):481-90, 538. PubMed ID: 20518320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric anaphylactic adverse events following immunization in Victoria, Australia from 2007 to 2013.
    Cheng DR; Perrett KP; Choo S; Danchin M; Buttery JP; Crawford NW
    Vaccine; 2015 Mar; 33(13):1602-7. PubMed ID: 25698493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse Events Following Immunization in Brazil: Age of Child and Vaccine-Associated Risk Analysis Using Logistic Regression.
    Lopes SRC; Perin JLR; Prass TS; Carvalho SMD; Lessa SC; Dórea JG
    Int J Environ Res Public Health; 2018 Jun; 15(6):. PubMed ID: 29865181
    [No Abstract]   [Full Text] [Related]  

  • 7. [Analysis of adverse events following 2009 influenza A (H1N1) vaccinoprophylaxis in Beijing].
    Miao L; Lu L; Wu J; Suo LD; Liu DL; Sun MP; Pang XH; Deng Y; Wang XL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Oct; 44(10):884-7. PubMed ID: 21176517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis on the characteristics of suspected vaccine-related deaths in Fujian Province, 2012-2017].
    Xiao JX; Lin ZQ; Wu RH; Zhou Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Jul; 53(7):719-723. PubMed ID: 31288344
    [No Abstract]   [Full Text] [Related]  

  • 9. Annual report: Surveillance of adverse events following immunisation in Australia, 2005.
    Lawrence G; Boyd I; McIntyre P; Isaacs D
    Commun Dis Intell Q Rep; 2006; 30(3):319-33. PubMed ID: 17120485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deaths reported to national surveillance for adverse events following immunization in China, 2010-2015.
    Wu W; Liu D; Nuorti JP; Li K; Xu D; Ye J; Zheng J; Cao L; Wang H
    Vaccine; 2019 Feb; 37(9):1182-1187. PubMed ID: 30709723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010.
    Ouandaogo CR; Yaméogo TM; Diomandé FV; Sawadogo C; Ouédraogo B; Ouédraogo-Traoré R; Pezzoli L; Djingarey MH; Mbakuliyemo N; Zuber PL
    Vaccine; 2012 May; 30 Suppl 2():B46-51. PubMed ID: 22230584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adverse events following immunization reported to the district sanitary-epidemiological station in Czestochowa in 2006-2010].
    Nowicki D; Gajewska L; Sosada KA
    Przegl Epidemiol; 2012; 66(4):667-72. PubMed ID: 23484397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of reporting rates of adverse events following immunization: an international comparison of post-marketing surveillance programs with reference to China.
    Guo B; Page A; Wang H; Taylor R; McIntyre P
    Vaccine; 2013 Jan; 31(4):603-17. PubMed ID: 23200940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surveillance of adverse events following immunization in Minhang district of Shanghai from 2007 to 2010].
    Zhang LP; Yu F; Jin BF; Wang Y; Xu HL; DU Y
    Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):859-64. PubMed ID: 23302620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The characteristics and trend of adverse events following immunization reported by information system in Jiangsu province, China, 2015-2018.
    Hu R; Peng S; Liu Y; Tang F; Wang Z; Zhang L; Gao J; Guo H
    BMC Public Health; 2021 Jul; 21(1):1338. PubMed ID: 34229643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance of adverse events following immunisation: Australia 2002 to 2003.
    Lawrence G; Boyd I; McIntyre P; Isaacs D
    Commun Dis Intell Q Rep; 2004; 28(3):324-38. PubMed ID: 15574056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of adverse events following immunisation: Australia, 2000-2002.
    Lawrence G; Menzies R; Burgess M; McIntyre P; Wood N; Boyd I; Purcell P; Isaacs D
    Commun Dis Intell Q Rep; 2003; 27(3):307-23. PubMed ID: 14510057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annual report: surveillance of adverse events following immunisation in Australia, 2008.
    Menzies R; Mahajan D; Gold MS; Roomiani I; McIntyre P; Lawrence G
    Commun Dis Intell Q Rep; 2009 Dec; 33(4):365-81. PubMed ID: 20301966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse events following immunization in patients with primary immunodeficiencies.
    Sarmiento JD; Villada F; Orrego JC; Franco JL; Trujillo-Vargas CM
    Vaccine; 2016 Mar; 34(13):1611-1616. PubMed ID: 26850760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cohort event monitoring to determine the adverse events following administration of mouse brain derived, inactivated Japanese Encephalitis vaccine in an endemic district in Sri Lanka.
    De Alwis KN; Abeysinghe MR; Wickramesinghe AR; Wijesinghe PR
    Vaccine; 2014 Feb; 32(8):924-30. PubMed ID: 24406391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.